InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the complete record of transactions filed by Williamson Robert F III. Director active across 1 company, notably Perspective Therapeutics, Inc.. Aggregated, 10 disclosures have been recorded. Split: 10 buys · 0 sell. Total volume traded: €196k. Activity tracked since 18 December 2023. The latest transaction was disclosed on 12 November 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Williamson Robert F III is a Director of Perspective Therapeutics, Inc. (XNAS). Across 10 filings total, the 10 sampled filings, all acquisitions, cover the period from 2023-12-19 to 2025-11-14, with buy volume of EUR 196424 and no sell volume indicated.